Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Nestor H. Garcia"'
Autor:
M. Reza Azarpazhooh, Ellisiv Mathiesen, Tatjana Rundek, Michel Romanens, Ansgar Adams, Luis Armando, Hernan Perez, Hugo Villafañe, Nestor H. Garcia, Borja Ibañez, Chrysi Bogiatzi, Reza Tabrizi, Valentín Fuster, J. David Spence
Publikováno v:
Neuroscience Institute Publications
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98299f1b765fa0acf805f2c770a9eebb
https://ir.lib.uwo.ca/context/neurosci_inst_pubs/article/1055/viewcontent/Azarpazhooh_20__20Reliability.pdf
https://ir.lib.uwo.ca/context/neurosci_inst_pubs/article/1055/viewcontent/Azarpazhooh_20__20Reliability.pdf
Autor:
Oscar Salva, Pablo Alexis Doreski, Celia Sara Giler, Dario Conrado Quinodoz, Lucia Guadalupe Guzman, Sonia Edith Munoz, Mariana N Carrillo, Daniela Josefina Porta, German Ambasch, Esteban Coscia, Jorge Luis Tambini Diaz, German David Bueno, Jorge Oscar Fandi, Miriam Angelica Maldonado, Leandro Eugenio Peña Chiappero, Fernando Fournier, Hernan Alejandro Pérez, Mauro Andres Quiroga, Javier Agustin Sala Mercado, Carlos Alberto Martínez Picco, Luis Alberto Argañaras, Nicolas Martinez Rios, Galia I. Kalayan, Dante Miguel Beltramo, Nestor H Garcia
BackgroundSodium-ibuprofenate in hypertonic saline (NaIHS) administered directly to the lungs by nebulization and inhalation has antibacterial and anti-inflammatory effects with the potential to deliver these benefits to hypoxic patients. We describe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0c0ea9ad42e0d831016b12865ebf437
https://doi.org/10.21203/rs.3.rs-390980/v1
https://doi.org/10.21203/rs.3.rs-390980/v1
Publikováno v:
Hypertension. 70
Cardiovascular risk is very high in CRF, but the underlying mechanisms are not well understood. Traditional cardiovascular risk factors (RF) do not explain the increased risk, and observational studies have observed paradoxical or absent associations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6491b80d3f37ea3fa1435d9710a9d57
https://doi.org/10.1161/hyp.70.suppl_1.p507
https://doi.org/10.1161/hyp.70.suppl_1.p507
Publikováno v:
Hypertension. 64
Although the positive family history for premature cardiovascular events has been considered a putative risk factor for decades, it has not been incorporated along with other established risk factors such as hyperlipidemia, hypertension, and cigarett
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21c36edf4a3ac541bd2a2b0b2c6aab16
https://doi.org/10.1161/hyp.64.suppl_1.237
https://doi.org/10.1161/hyp.64.suppl_1.237
Publikováno v:
Hypertension. 64
During hypertension kidney fails to maintain Na balance, leading to increased blood volume and blood pressure. It has been suggested that humoral defects and in the last decade in Na transport disorders have been described in different tubular segmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5352f8eb96f4cd797928fd1f13e11f0e
https://doi.org/10.1161/hyp.64.suppl_1.302
https://doi.org/10.1161/hyp.64.suppl_1.302
Publikováno v:
Hypertension. 62
Coronary heart disease (CHD) is the leading cause of death among women. Currently, global risk assessment derived by a Framingham risk equation is used to identify women at increased risk, but still we do not detect them early enough to decrease the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7694c88f0750e864fe5cd9943ec5766c
https://doi.org/10.1161/hyp.62.suppl_1.a614
https://doi.org/10.1161/hyp.62.suppl_1.a614
Publikováno v:
Hypertension. 62
The onset of symptoms of coronary heart disease in women are displaced a decade compared with men after menopause, but currently there are reports in which 1 in 4 women is less than 59 years, suggesting that in the pre-menopausal period there is mark
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8170945e3f9ac1917d94494f4646154d
https://doi.org/10.1161/hyp.62.suppl_1.a615
https://doi.org/10.1161/hyp.62.suppl_1.a615
Publikováno v:
American Journal of Physiology-Renal Physiology. 270:F206-F210
Nitric oxide (NO) reduces blood pressure in vivo by two mechanisms, vasodilation and increasing urinary volume: however, the exact mechanism by which it increases urinary volume is not clear. We hypothesized that NO inhibits antidiuretic hormone (ADH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6d9b713b28c40472dc764f87e206dba
https://doi.org/10.1152/ajprenal.1996.270.1.f206
https://doi.org/10.1152/ajprenal.1996.270.1.f206
Publikováno v:
Journal of the American Society of Nephrology. 6:89-94
Indirect evidence suggests that nitric oxide inhibits sodium reabsorption by the collecting duct; however, direct evidence is lacking. It was hypothesized that endothelium-derived nitric oxide inhibits sodium flux in the cortical collecting duct by b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c89d2f372ddfeb571b96742daa86c86
https://doi.org/10.1681/asn.v6189
https://doi.org/10.1681/asn.v6189
Autor:
Nestor H. Garcia, Jeffrey L. Garvin
Publikováno v:
American Journal of Physiology-Renal Physiology. 268:F730-F735
Atrial natriuretic factor (ANF) inhibits fluid absorption (Jv) in the proximal straight tubule (PST) only after stimulation with angiotensin II (ANG II). To investigate ANF's dependency on ANG II for transport inhibition, we blocked and mimicked angi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::606402a15387882cf79c4aabc711950a
https://doi.org/10.1152/ajprenal.1995.268.4.f730
https://doi.org/10.1152/ajprenal.1995.268.4.f730